Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Adjuvant System AS01 is a liposome-based vaccine adjuvant containing 3-O-desacyl-4′-monophosphoryl lipid A and the saponin QS-21. AS01 has been selected for the clinical development of several candidate vaccines including the RTS,S malaria vaccine and the subunit glycoprotein E varicella zoster vaccine (both currently in phase III). Given the known immunostimulatory properties of MPL and QS-21, the objective of this study was to describe the early immune response parameters after immunization with an AS01-adjuvanted vaccine and to identify relationships with the vaccine-specific adaptive immune response. Cytokine production and innate immune cell recruitment occurred rapidly and transiently at the muscle injection site and draining lymph node postinjection, consistent with the rapid drainage of the vaccine components to the draining lymph node. The induction of Ag-specific Ab and T cell responses was dependent on the Ag being injected at the same time or within 24 h after AS01, suggesting that the early events occurring postinjection were required for these elevated adaptive responses. In the draining lymph node, after 24 h, the numbers of activated and Ag-loaded monocytes and MHCIIhigh dendritic cells were higher after the injection of the AS01-adjuvanted vaccine than after Ag alone. However, only MHCIIhigh dendritic cells appeared efficient at and necessary for direct Ag presentation to T cells. These data suggest that the ability of AS01 to improve adaptive immune responses, as has been demonstrated in clinical trials, is linked to a transient stimulation of the innate immune system leading to the generation of high number of efficient Ag-presenting dendritic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, these results have been obtained in young mice, and it is still not known if this mechanisms are preserved in aged animals [174].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [174]
Citations
Cites
Neutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3024 · Cited by 3,027
Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., & Chazaud, B. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070075 · Cited by 2,002
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,924
Jung, S., Unutmaz, D., Wong, P., Sano, G.-I., De los Santos, K., Sparwasser, T., Wu, S., Vuthoori, S., Ko, K., Zavala, F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00365-5 · Cited by 1,773
Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells
Auffray, C., Sieweke, M. H., & Geissmann, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132557 · Cited by 1,655
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Self-citationFirst Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
The RTS, S. C. T. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102287 · Cited by 896
Didierlaurent, A. M., Morel, S., Lockman, L., Giannini, S. L., Bisteau, M., Carlsen, H., Kielland, A., Vosters, O., Vanderheyde, N., Schiavetti, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901474 · Cited by 758
Self-citationA Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
The RTS, S. C. T. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208394 · Cited by 752 · cited 2×
“Recently, the RTS,S vaccine was shown to confer protection of 30–47% against uncomplicated and severe malaria in young African children and infants, respectively (17, 18).”
BackgroundHEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes
Girard, J.-P., Moussion, C., & Förster, R. (2012) · Nature Reviews Immunology · doi:10.1038/nri3298 · Cited by 713
Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP3
Li, H., Willingham, S. B., Ting, J. P.-Y., & Re, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.17 · Cited by 675
Kensil, C. R., Patel, U., Lennick, M., & Marciani, D. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.2.431 · Cited by 654
The function of Fcγ receptors in dendritic cells and macrophages
Guilliams, M., Bruhns, P., Saeys, Y., Hammad, H., & Lambrecht, B. N. (2014) · Nature Reviews Immunology · doi:10.1038/nri3582 · Cited by 639
Self-citationKool, M., Pétrilli, V., De Smedt, T., Rolaz, A., Hammad, H., van Nimwegen, M., Bergen, I. M., Castillo, R., Lambrecht, B. N., & Tschopp, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3755 · Cited by 611
Self-citationKester, K. E., Cummings, J. F., Ofori‐Anyinam, O., Ockenhouse, C. F., Krzych, U., Moris, P., Schwenk, R., Nielsen, R. A., Debebe, Z., Pinelis, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600120 · Cited by 524
The mechanism of action of MF59 – An innately attractive adjuvant formulation
O’Hagan, D. T., Ott, G. S., De Gregorio, E., & Seubert, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.09.061 · Cited by 488
Morel, S., Didierlaurent, A., Bourguignon, P., Delhaye, S., Baras, B., Jacob, V., Planty, C., Elouahabi, A., Harvengt, P., & Carlsen, H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.011 · Cited by 476
Self-citationRe(de)fining the dendritic cell lineage
Satpathy, A. T., Wu, X., Albring, J. C., & Murphy, K. M. (2012) · Nature Immunology · doi:10.1038/ni.2467 · Cited by 441
Calabro, S., Tortoli, M., Baudner, B. C., Pacitto, A., Cortese, M., O’Hagan, D. T., De Gregorio, E., Seubert, A., & Wack, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.090 · Cited by 433
Groom, J. R., Richmond, J., Murooka, T. T., Sorensen, E. W., Sung, J. H., Bankert, K., von Andrian, U. H., Moon, J. J., Mempel, T. R., & Luster, A. D. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.016 · Cited by 433
Mechanism of action of clinically approved adjuvants
Lambrecht, B. N., Kool, M., Willart, M. A., & Hammad, H. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.004 · Cited by 354
Self-citationNakano, H., Lin, K. L., Yanagita, M., Charbonneau, C., Cook, D. N., Kakiuchi, T., & Gunn, M. D. (2009) · Nature Immunology · doi:10.1038/ni.1707 · Cited by 341
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Garçon, N., & Van Mechelen, M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.29 · Cited by 314
Self-citationLanglet, C., Tamoutounour, S., Henri, S., Luche, H., Ardouin, L., Grégoire, C., Malissen, B., & Guilliams, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102744 · Cited by 284
Self-citationFour-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
Olotu, A., Fegan, G., Wambua, J., Nyangweso, G., Awuondo, K. O., Leach, A., Lievens, M., Leboulleux, D., Njuguna, P., Peshu, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1207564 · Cited by 270
Antigen persistence is required throughout the expansion phase of a CD4+ T cell response
Obst, R., van Santen, H.-M., Mathis, D., & Benoist, C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042521 · Cited by 269
Soudja, S. M., Ruiz, A. L., Marie, J. C., & Lauvau, G. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.029 · Cited by 263
Domínguez, P. M., & Ardavín, C. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00876.x · Cited by 254
Vandepapelière, P., Horsmans, Y., Moris, P., Van Mechelen, M., Janssens, M., Koutsoukos, M., Van Belle, P., Clement, F., Hanon, E., Wettendorff, M., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.038 · Cited by 218
Self-citationLivingston, P. O., Adluri, S., Helling, F., Yao, T.-J., Kensilt, C. R., Newman, M. J., & Marciani, D. (1994) · Vaccine · doi:10.1016/s0264-410x(94)80052-2 · Cited by 214
Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer
Ragupathi, G., Gardner, J. R., Livingston, P. O., & Gin, D. Y. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.18 · Cited by 206
Soltysik, S., Wu, J.-Y., Recchia, J., Wheeler, D. A., Newman, M. J., Coughlin, R. T., & Kensil, C. R. (1995) · Vaccine · doi:10.1016/0264-410x(95)00077-e · Cited by 188
Monophosphoryl Lipid A Activates Both Human Dendritic Cells and T Cells
Ismaili, J., Rennesson, J., Aksoy, E., Vekemans, J., Vincart, B., Amraoui, Z., Van Laethem, F., Goldman, M., & Dubois, P. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.926 · Cited by 183
The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells
De Becker, G., Moulin, V., Pajak, B., Bruck, C., Francotte, M., Thiriart, C., Urbain, J., & Moser, M. (2000) · International Immunology · doi:10.1093/intimm/12.6.807 · Cited by 182
Yang, C.-W., Strong, B. S. I., Miller, M. J., & Unanue, E. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001289 · Cited by 177
From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets
Guilliams, M., Henri, S., Tamoutounour, S., Ardouin, L., Schwartz-Cornil, I., Dalod, M., & MALISSEN, B. (2010) · European Journal of Immunology · doi:10.1002/eji.201040498 · Cited by 171
Self-citationLeroux-Roels, I., Forgus, S., De Boever, F., Clement, F., Demoitié, M.-A., Mettens, P., Moris, P., Ledent, E., Leroux-Roels, G., & Ofori-Anyinam, O. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.05.035 · Cited by 165
Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
Polhemus, M. E., Remich, S. A., Ogutu, B. R., Waitumbi, J. N., Otieno, L., Apollo, S., Cummings, J. F., Kester, K. E., Ockenhouse, C. F., Stewart, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006465 · Cited by 161
Dendouga, N., Fochesato, M., Lockman, L., Mossman, S. P., & Giannini, S. L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.088 · Cited by 156
Self-citationQS-21: a water-soluble triterpene glycoside adjuvant
Kensil, C. R., & Kammer, R. B. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.9.1475 · Cited by 152
Innate control of adaptive immunity via remodeling of lymph node feed arteriole
Soderberg, K. A., Payne, G. W., Sato, A., Medzhitov, R., Segal, S. S., & Iwasaki, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506190102 · Cited by 148
Park, M. K., Amichay, D., Love, P., Wick, E., Liao, F., Grinberg, A., Rabin, R. L., Zhang, H. H., Gebeyehu, S., Wright, T. M., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1433 · Cited by 131
Combination adjuvants: the next generation of adjuvants?
Mutwiri, G., Gerdts, V., den Hurk, S. V. D. L., Auray, G., Eng, N. F., Garlapati, S., Babiuk, L. A., & Potter, A. A. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.154 · Cited by 123
Duewell, P., Kisser, U., Heckelsmiller, K., Hoves, S., Stoitzner, P., Koernig, S., Morelli, A. B., Clausen, B. E., Dauer, M., Eigler, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004114 · Cited by 111
Olotu, A., Moris, P., Mwacharo, J. K., Vekemans, J., Kimani, D., Janssens, M., Kai, O. K., Jongert, E., Lievens, M., Leach, A. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025786 · Cited by 105
ISCOMATRIX vaccines mediate CD8+ T‐cell cross‐priming by a MyD88‐dependent signaling pathway
Wilson, N. S., Yang, B., Morelli, A. B., Koernig, S., Yang, A., Loeser, S., Airey, D., Provan, L., Hass, P., Braley, H., et al. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.71 · Cited by 101
Schnurr, M., Orban, M., Robson, N. C., Shin, A., Braley, H., Airey, D., Cebon, J., Maraskovsky, E., & Endres, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1253 · Cited by 100
Kamath, A. T., Mastelic, B., Christensen, D., Rochat, A., Agger, E. M., Pinschewer, D. D., Andersen, P. L., Lambert, P., & Siegrist, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103183 · Cited by 80
Leroux‐Roels, I., Koutsoukos, M., Clément, F., Steyaert, S., Janssens, M., Bourguignon, P., Cohen, K. W., Altfeld, M. A., Vandepapelière, P., Pedneault, L., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.035 · Cited by 78
Self-citationVan Braeckel, E., Bourguignon, P., Koutsoukos, M., Clement, F., Janssens, M., Carletti, I., Collard, A., Demoitié, M.-A., Voss, G., Leroux-Roels, G., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq160 · Cited by 62
Self-citationSuppression of Vaccine Immunity by Inflammatory Monocytes
Mitchell, L., Henderson, A. J., & DOW, S. W. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202151 · Cited by 48
Ndungu, F. M., Mwacharo, J. K., Kimani, D., Kai, O. K., Moris, P., Jongert, E., Vekemans, J., Olotu, A., & Bejon, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052870 · Cited by 46
Dynamics of dendritic cell–T cell interactions: a role in T cell outcome
Hugues, S. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-010-0211-2 · Cited by 41
T‐zone localized monocyte‐derived dendritic cells promote Th1 priming to Salmonella
Flores‐Langarica, A., Marshall, J. L., Bobat, S., Mohr, E., Hitchcock, J. R., Ross, E. A., Coughlan, R. E., Khan, M., van Rooijen, N., Henderson, I. R., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141440 · Cited by 41
Vaccine Adjuvants: Immunological and Clinical Principles.
Cross, A. S. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.4.0740701 · Cited by 16
Monophosphoryl Lipid A and Synthetic Lipid A Mimetics As TLR4-Based Adjuvants and Immunomodulators
Baldridge, J. R., Myers, K. R., Johnson, D. A., Persing, D. H., Cluff, C. W., & Hershberg, R. M. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-970-7_12 · Cited by 15
Cited by
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Lal, H., Cunningham, A. L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S.-J., Levin, M. J., McElhaney, J. E., Poder, A., Puig-Barberà, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501184 · Cited by 1,454
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Del Giudice, G., Rappuoli, R., & Didierlaurent, A. M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.05.001 · Cited by 610
Self-citationAdjuvant system AS01: helping to overcome the challenges of modern vaccines
Didierlaurent, A. M., Laupèze, B., Di Pasquale, A., Hergli, N., Collignon, C., & Garçon, N. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1213632 · Cited by 516
“Concentrations of cytokines in muscle and draining lymph node after injection with AS01 and gE antigen (data from [34]).”
BackgroundSelf-citationThe how’s and what’s of vaccine reactogenicity
Hervé, C., Laupèze, B., Del Giudice, G., Didierlaurent, A. M., & Tavares Da Silva, F. (2019) · npj Vaccines · doi:10.1038/s41541-019-0132-6 · Cited by 513
Self-citationAging of the immune system: Focus on inflammation and vaccination
Pinti, M., Appay, V., Campisi, J., Frasca, D., Fülöp, T., Sauce, D., Larbi, A., Weinberger, B., & Cossarizza, A. (2016) · European Journal of Immunology · doi:10.1002/eji.201546178 · Cited by 439
Metadata
- Authors
- Didierlaurent, A. M., Collignon, C., Bourguignon, P., Wouters, S., Fierens, K., Fochesato, M., Dendouga, N., Langlet, C., Malissen, B., Lambrecht, B. N., Garçon, N., Van Mechelen, M., & Morel, S.
- Affiliations
- GlaxoSmithKline (Belgium) (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Centre National de la Recherche Scientifique (FR)
- GlaxoSmithKline Vaccines , 1330 Rixensart ,
- Corresponding author
- Collignon, Catherine
- Bourguignon, Patricia
- Wouters, Sandrine
- Fochesato, Michel
- Dendouga, Najoua
- Langlet, Christelle
- Morel, Sandra
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-08
- Volume
- 193
- Issue
- 4
- Pages
- 1920-1930
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1942950379
- Cited by
- 266
- References
- 56
- Citations by year
- 2026: 14 · 2025: 25 · 2024: 15 · 2023: 23 · 2022: 31 · 2021: 26 · 2020: 19 · 2019: 28 · 2018: 14 · 2017: 37 · 2016: 21 · 2015: 10 · 2014: 2
- FWCI
- 10.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- MPL, QS-21, dendritic cells, adaptive immune response, antigen presentation, MHC class II, monocytes, draining lymph nodes, cytokine production, innate immune activation, RTS,S malaria vaccine, varicella-zoster vaccine, T cell response, antibody response
- MeSH terms
- Adjuvants, Immunologic, Animals, Histocompatibility Antigens Class II, B-Lymphocytes, Dendritic Cells, Drug Combinations, Female, Humans, Lipid A, Lymphocyte Activation, Mice, Inbred C57BL, Monocytes, Saponins, Vaccination, Vaccines, CD4-Positive T-Lymphocytes, Antigen Presentation, CD8-Positive T-Lymphocytes, Mice, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.